SK bioscience Co.,Ltd.
KRX:302440.KS
53800 (KRW) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 127,025.639 | 225,287.448 | 98,028.261 | 24,972.321 | 14,380.269 | 4,489.19 |
| Short Term Investments
| 1,147,115.603 | 1,255,518.125 | 1,547,635.054 | 183,735.898 | 80,088.335 | 99,188.908 |
| Cash and Short Term Investments
| 1,274,141.242 | 1,480,805.573 | 1,645,663.315 | 208,708.218 | 94,468.604 | 103,678.098 |
| Net Receivables
| 22,342.473 | 115,482.78 | 57,094.958 | 54,918.629 | 39,894.796 | 45,175.161 |
| Inventory
| 80,649.374 | 187,405.858 | 135,045.958 | 70,275.31 | 36,377.862 | 31,875.729 |
| Other Current Assets
| 5,836.396 | -0 | -0 | 0 | 0 | 0 |
| Total Current Assets
| 1,382,969.484 | 1,783,694.21 | 1,837,804.231 | 333,902.157 | 170,741.263 | 180,728.987 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 315,923.229 | 293,056.611 | 220,983.379 | 189,478.939 | 190,770.022 | 172,830.831 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 22,458.595 | 18,181.33 | 17,061.308 | 17,857.57 | 19,479.008 | 21,839.063 |
| Goodwill and Intangible Assets
| 22,458.595 | 18,181.33 | 17,061.308 | 17,857.57 | 19,479.008 | 21,839.063 |
| Long Term Investments
| 42,815.043 | -1,250,373.341 | -1,522,054.527 | -183,280.67 | -79,610.631 | -98,832.944 |
| Tax Assets
| 59,218.878 | 21,369.852 | 10,241.571 | 20,442.618 | 11,894.502 | 15,889.247 |
| Other Non-Current Assets
| 29,053.952 | 1,276,002.721 | 1,546,086.71 | 183,831.157 | 90,705.946 | 110,259.428 |
| Total Non-Current Assets
| 469,469.697 | 358,237.173 | 272,318.441 | 228,329.614 | 233,238.847 | 221,985.625 |
| Total Assets
| 1,852,439.18 | 2,141,931.384 | 2,110,122.672 | 562,231.772 | 403,980.11 | 402,714.613 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 3,370.136 | 11,053.234 | 63,811.952 | 17,505.191 | 18,372.076 | 11,077.028 |
| Short Term Debt
| 8,137.402 | 95,792.981 | 61,958.323 | 12,608.089 | 1,350.756 | 11,410.935 |
| Tax Payables
| 0 | 20,215.888 | 112,210.77 | 5,263.608 | 77.748 | 0 |
| Deferred Revenue
| 76,956.9 | 193,428.039 | 334,181.889 | 150,526.214 | 25,786.568 | 35,422 |
| Other Current Liabilities
| 47,155.458 | 79,763.173 | 0 | 0.001 | -0.001 | 3,929.502 |
| Total Current Liabilities
| 135,619.896 | 380,037.427 | 459,952.164 | 180,639.495 | 45,509.4 | 61,839.465 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 12,436.126 | 17,543.212 | 44,277.261 | 109,358.977 | 123,721.393 | 126,549.572 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | -27,184.679 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 27,184.679 | 0 | 0 |
| Other Non-Current Liabilities
| 527.842 | 2,648.749 | 4,581.298 | 8,443.055 | 2,015.143 | 3,592.131 |
| Total Non-Current Liabilities
| 12,963.968 | 20,191.96 | 48,858.559 | 117,802.032 | 125,736.536 | 130,141.703 |
| Total Liabilities
| 148,583.864 | 400,229.387 | 508,810.724 | 298,441.527 | 171,245.935 | 191,981.168 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 564.04 | 993.762 | 1,217.055 |
| Common Stock
| 38,413.875 | 38,392.023 | 38,250 | 30,600 | 10,200 | 10,200 |
| Retained Earnings
| 549,420.553 | 533,377.516 | 405,305.164 | 53,236.251 | 22,308.448 | 531.011 |
| Accumulated Other Comprehensive Income/Loss
| -44,435.051 | 9,924.326 | 692.921 | -564.04 | -993.762 | -1,217.055 |
| Other Total Stockholders Equity
| 1,160,455.939 | 1,160,008.131 | 1,157,063.863 | 179,953.994 | 200,225.726 | 200,002.433 |
| Total Shareholders Equity
| 1,703,855.316 | 1,741,701.996 | 1,601,311.948 | 263,790.244 | 232,734.174 | 210,733.444 |
| Total Equity
| 1,703,855.316 | 1,741,701.996 | 1,601,311.948 | 263,790.244 | 232,734.174 | 210,733.444 |
| Total Liabilities & Shareholders Equity
| 1,852,439.18 | 2,141,931.384 | 2,110,122.672 | 562,231.772 | 403,980.11 | 402,714.613 |